Article

CURE New Issue Alert: Hematology Special Issue

September is Blood Cancer Awareness month and CURE’s latest issue is dedicated to these diseases. And we have a sneak peek at what’s inside:

September is Blood Cancer Awareness month and CURE’s latest issue is dedicated to these diseases. And we have a sneak peek at what’s inside:

Our cover story explores how researchers are Taking a Shot with subcutaneous injections to fight cancers such as multiple myeloma and lymphoma. So far, this method has shown to have fewer side effects and shorter times at the clinic.

Next, A Little of Everything is being used when it comes to treating patients with non-Hodgkin lymphoma. Targeted therapies, immunotherapies and new combinations show promise for the nearly 75,000 adults and children in the United States that are affected by the disease each year.

And, innovative techniques bring new options for people in need of a stem cell transplant. Read the stories of patients who were able to Strike a Match and defy the odds.

Also inside, a team of 16 people walk through “Fire and Ice” for a cause — raising money to help find a cure for multiple myeloma. CURE takes you inside their trek to Iceland.

To read these stories and more, visit https://www.curetoday.com/publications/cure/2018/hematology-2-2018.

Or, ensure you don’t miss a story when you subscribe to new issue alerts. Visit curetoday.com/email-profile for more information.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of man with text.
The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing benefits across diverse patients.
Clinical Trial Evaluating Monjuvi in Lymphoma Gives Lasting Responses